Lycia Therapeutics, Inc. — Form D

Lycia Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-17. The offering totals $50.4M, of which $25.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Jeremy S CaldwellDirectorSan Diego, CA
Laurent S FischerDirectorSan Diego, CA
Clare S OzawaDirectorSan Diego, CA
Thomas S WoiwodeDirectorSan Diego, CA
Jeremy S CaldwellExecutive OfficerSan Diego, CA
Ming FangDirectorSouth San Francisco, CA
Ming FangRelated PersonSouth San Francisco, CA
Tim AndersonDirectorSouth San Francisco, CA
Tim AndersonRelated PersonSouth San Francisco, CA
Clare OzawaDirectorSouth San Francisco, CA
Clare OzawaRelated PersonSouth San Francisco, CA
Laurent FischerDirectorSouth San Francisco, CA
Laurent FischerRelated PersonSouth San Francisco, CA
Andrew GottesdienerDirectorSouth San Francisco, CA
William RieflinDirectorSouth San Francisco, CA
William RieflinRelated PersonSouth San Francisco, CA
Aetna Wun TrombleyDirectorSouth San Francisco, CA
Aetna Wun TrombleyExecutive OfficerSouth San Francisco, CA
Aetna Wun TrombleyRelated PersonSouth San Francisco, CA
Thomas WoiwodeDirectorSan Francisco, CA
Amy BachrodtRelated PersonSouth San Francisco, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2026-06-25D$75.0M$75.0M
2024-05-23D$106.6M$106.6M
2021-09-16D$70.1M$70.1M

More